Beijing Anzhen Hospital. Capital Medical University ( Site 1917)

Beijing, Beijing Municipality 100029

1 studies enrolling now · 1 studies all time

What they study most

Heterozygous Familial Hypercholesterolemia (HeFH)

Studies at this site

• A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029) — Recruiting now